Frontier Biotechnologies Inc
SSE:688221
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Frontier Biotechnologies Inc (688221) under the Base Case is CNY per share. Compared with the current market price of 13.62 CNY, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Frontier Biotechnologies Does
Frontier Biotechnologies is a Chinese biopharmaceutical company focused mainly on treatments for HIV and other infectious diseases. Its best-known product is a prescription drug used as part of HIV treatment, and it also works on additional drug candidates for diseases where patients need long-term antiviral therapy. The company’s core job is to discover, develop, and bring these medicines to market.
- Headquarters
- China CN
- Employees
- 314
- IPO date
- Oct 28, 2020
Earnings Waterfall
Frontier Biotechnologies Inc
What is the Intrinsic Value of one Frontier Biotechnologies Inc stock?
The intrinsic value for Frontier Biotechnologies Inc (688221) under the Base Case is CNY.
Is Frontier Biotechnologies Inc stock undervalued or overvalued?
Compared with the current market price of 13.62 CNY, the stock appears .